Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OC-10X in Proliferative Diabetic Retinopathy
NCT02735369Phase 2Terminated
- Sponsor
- OcuCure Therapeutics
- Start
- Dec 2014
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of OC-10X in proliferative diabetic retinopathy (PDR), sponsored by OcuCure Therapeutics. Started Dec 2014; status: terminated.
02
Drugs
OC-10X
03
Conditions
proliferative diabetic retinopathy (PDR)
Beyond the preview
Go deeper on NCT02735369.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02735369.